Brad W Greenfield

Title: Brad W Greenfield: Innovator in Artificial Proteoglycans

Introduction

Brad W Greenfield is a notable inventor based in Edmonds, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of artificial proteoglycans. His work focuses on enhancing biological activity and therapeutic applications in various medical conditions.

Latest Patents

Brad W Greenfield holds a patent for "Artificial proteoglycans," which includes novel artificial proteoglycans containing a glycosaminoglycan (GAG) assembly site and a control sequence required for assembly. This invention outlines methods for enhancing the biological activity of glycosaminoglycan binding proteins using artificial proteoglycans. The applications of these artificial proteoglycans are extensive, including their use in adjuvants for vaccination, targeting chemokines to non-immunogenic tumor cells to enhance cellular anti-tumor responses, promoting wound healing, and treating immunological disorders such as rheumatoid arthritis, asthma, chronic obstructive pulmonary disorder, lupus, inflammatory bowel disease, psoriasis, osteoarthritis, and HIV infection.

Career Highlights

Brad W Greenfield is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to advancements in medical science. His work has the potential to impact various therapeutic areas significantly.

Collaborations

Throughout his career, Brad has collaborated with esteemed colleagues, including Kelly L Bennett and Edith A Wolff. These collaborations have further enriched his research and development efforts.

Conclusion

Brad W Greenfield is a pioneering inventor whose work on artificial proteoglycans holds promise for numerous medical applications. His contributions to biotechnology are noteworthy and continue to influence the field positively.